Washington University in St. Louis (WU)

Andrea Wang-Gillam, MD, PhD

Associate Professor of Medicine

My research interest is developing new therapeutic agents for pancreatic cancer. The mammalian target of rapamycin (mTOR) is a downstream mediator in the phosphatidylinositol 3-kinase (PI3K) pathway ...

Saiama N. Waqar, MD

Assistant Professor of Medicine

Clinical interests: treatment of lung cancer Research interests: predictors of recurrence in patients with early stage non-small cell lung cancer (NSCLC), clinical and molecular predictors of brain ...

Mark E. Warchol, PhD

Development & regeneration of the sensory hair cells & afferent neurons of the inner ear.

Jeffrey P. Ward, MD, PhD

Instructor of Medicine

My research focuses on the identification of tumor specific mutant antigens recognized by the immune system as foreign that serve as the target of a T-cell response against tumors. We take advantage ...

Barbara B. Warner, MD, MS

Professor of Pediatrics

Clinical interest is in identifying the underlying pathogenesis of necrotizing enterocolitis (NEC) in infants, specifically, evaluating the role of epidermal growth factor (EGF) in NEC prevention. ...

John M. Warrington, MD, MS

DBBS Pre Doc Trainee

I am interested in modulating the immune system to fight cancer. Particularly interested in combining computation with wet lab approaches to drive innovative solutions.

Lukas D. Wartman, MD

Assistant Professor of Medicine

For the next 2-3 years, I will be a research fellow in Tim Ley's laboratory. My research project centers around the genomics of Acute Promyelocytic Leukemia, both in a mouse model and in human ...

Karla T. Washington, PhD

Associate Professor of Medicine

Palliative medicine, family caregiving, digital health, intervention research, psychosocial wellbeing

Will Wasielewski, BA

Predoctoral Researcher

Rare genetic disorders of insulin resistance.

Erika A. Waters, MPH, PhD, MS

Professor of Surgery (General Surgery)

I investigate how thoughts about cancer risk (i.e., cancer cognitions) influence laypeople’s medical decisions and engagement in cancer prevention behaviors. To date, my research has focused on risk ...